These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22910911)

  • 21. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Nagai R; Miyata S; Jono T; Horiuchi S; Hirano A; Kato S; Sasaki S; Asayama K; Kobayashi M
    Acta Neuropathol; 2000 Sep; 100(3):275-84. PubMed ID: 10965797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotinamide Adenine Dinucleotide Precursor Supplementation Modulates Neurite Complexity and Survival in Motor Neurons from Amyotrophic Lateral Sclerosis Models.
    Hamilton HL; Akther M; Anis S; Colwell CB; Vargas MR; Pehar M
    Antioxid Redox Signal; 2024 Sep; 41(7-9):573-589. PubMed ID: 38504592
    [No Abstract]   [Full Text] [Related]  

  • 23. CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A.
    La Cognata V; D'Amico AG; Maugeri G; Morello G; Guarnaccia M; Magrì B; Aronica E; D'Agata V; Cavallaro S
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang Q; Martin LJ
    J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.
    Tortarolo M; Veglianese P; Calvaresi N; Botturi A; Rossi C; Giorgini A; Migheli A; Bendotti C
    Mol Cell Neurosci; 2003 Jun; 23(2):180-92. PubMed ID: 12812752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS.
    Noristani HN; Sabourin JC; Gerber YN; Teigell M; Sommacal A; Vivanco Md; Weber M; Perrin FE
    Mol Neurodegener; 2015 Aug; 10():34. PubMed ID: 26227626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
    Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
    J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Lee JD; Kamaruzaman NA; Fung JN; Taylor SM; Turner BJ; Atkin JD; Woodruff TM; Noakes PG
    J Neuroinflammation; 2013 Sep; 10():119. PubMed ID: 24067070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.
    McLeod VM; Chiam MDF; Lau CL; Rupasinghe TW; Boon WC; Turner BJ
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32621747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation.
    Diaz-Amarilla P; Miquel E; Trostchansky A; Trias E; Ferreira AM; Freeman BA; Cassina P; Barbeito L; Vargas MR; Rubbo H
    Free Radic Biol Med; 2016 Jun; 95():112-20. PubMed ID: 27012417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Guo YS; Wu DX; Wu HR; Wu SY; Yang C; Li B; Bu H; Zhang YS; Li CY
    Exp Mol Med; 2009 Mar; 41(3):140-50. PubMed ID: 19293633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.
    Vargas MR; Johnson DA; Sirkis DW; Messing A; Johnson JA
    J Neurosci; 2008 Dec; 28(50):13574-81. PubMed ID: 19074031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.